Colossal Biosciences has introduced the GenoMorph AI platform to identify gene-editing targets for de-extinction projects, starting with the dodo.
Colossal Biosciences has launched an AI platform called GenoMorph to identify genetic targets for de-extinction projects, starting with the dodo bird.
Stanford University researchers have successfully used artificial intelligence to generate a novel virus, marking a significant step in the development of synthetic biology.
Italian biotech startup Aptadir Therapeutics has raised $45 million in a seed round to advance its RNA inhibitor technology for treating genetic conditions.
Anthropic's AI agents have identified a potential new gene-editing system, but the scientific community remains skeptical about the significance of the preliminary findings.
Basecamp Research has raised $140 million to advance its biological AI models and develop new cell therapies using genetic data from global ecosystems.
Roscosmos may introduce genetic radiation resistance as a selection factor for future interplanetary missions to mitigate health risks beyond Earth's orbit.
Google DeepMind has launched the AlphaGenome Atlas, a 1-petabyte database mapping the potential effects of 9 billion single-letter mutations in human DNA.
Google has introduced AlphaGenome, an AI system that evaluates the functional potential of every possible single-base change within the human genome.
